CID 9826472

Sorafenib n-oxide

Structural Information

Molecular Formula
C21H16ClF3N4O4
SMILES
CNC(=O)C1=[N+](C=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)[O-]
InChI
InChI=1S/C21H16ClF3N4O4/c1-26-19(30)18-11-15(8-9-29(18)32)33-14-5-2-12(3-6-14)27-20(31)28-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,27,28,31)
InChIKey
BQAZCCVUZDIZDC-UHFFFAOYSA-N
Compound name
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxidopyridin-1-ium-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

6899
References

341
Patents

480.0812 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 481.08848 193.7
[M+Na]+ 503.07042 204.0
[M+NH4]+ 498.11502 196.6
[M+K]+ 519.04436 201.3
[M-H]- 479.07392 195.1
[M+Na-2H]- 501.05587 199.9
[M]+ 480.08065 195.3
[M]- 480.08175 195.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe